R

Rachel O. Abelman

Massachusetts General Hospital

ORCID: 0000-0002-3946-7420

Publishes on HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology. 67 papers and 473 citations.

🌱#5 Emerging Leader in antibody drug conjugates· PubIndex 50
67Publications
473Total Citations
#5in antibody drug conjugates
First publication: 2014First senior author: 2021
HER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesCancer Treatment and PharmacologyCancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies Research

Top publicationsby citations

No publications found